Skip to main content

Revolution Medicines, Inc.

corporate_fare Company Profile

Revolution Medicines, Inc.

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed RVMD - Latest Insights

RVMD
Apr 17, 2026, 5:16 PM EDT
Filing Type: 8-K
Importance Score:
8
RVMD
Apr 17, 2026, 4:02 PM EDT
Source: GlobeNewswire
Importance Score:
7
RVMD
Apr 16, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
9
RVMD
Apr 16, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
9
RVMD
Apr 15, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
9
RVMD
Apr 15, 2026, 5:24 PM EDT
Filing Type: 424B5
Importance Score:
9
RVMD
Apr 15, 2026, 6:00 AM EDT
Filing Type: FWP
Importance Score:
9
RVMD
Apr 15, 2026, 12:41 AM EDT
Source: GlobeNewswire
Importance Score:
9
RVMD
Apr 13, 2026, 4:39 PM EDT
Filing Type: 424B5
Importance Score:
8
RVMD
Apr 13, 2026, 4:36 PM EDT
Filing Type: 424B5
Importance Score:
9
RVMD
Apr 13, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
RVMD
Apr 13, 2026, 8:25 AM EDT
Filing Type: 8-K
Importance Score:
9
RVMD
Apr 13, 2026, 8:00 AM EDT
Source: Reuters
Importance Score:
9
RVMD
Apr 02, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
RVMD
Mar 17, 2026, 6:37 PM EDT
Source: GlobeNewswire
Importance Score:
8
RVMD
Feb 25, 2026, 5:05 PM EST
Filing Type: 424B5
Importance Score:
8
RVMD
Feb 25, 2026, 4:11 PM EST
Filing Type: 10-K
Importance Score:
8
RVMD
Feb 25, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7